Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on June 2, 2025
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025
GlobeNewswire
·
June 2, 2025
Updated interim data remain consistent, showing 10.3-month median PFS overall and 11.0-month median PFS in 2L patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer Data continue to support planned initiation of pivotal study in mid-2025 Next- …
Sanofi Exercises License Extension Option to Nurix’s STAT6 Program
GlobeNewswire
·
June 2, 2025
STAT6 is a key transcription factor within the IL4/IL13 signaling pathways which act as drivers of inflammation in allergic conditions Nurix to receive a $15 million license extension fee from Sanofi under its 2019 collaboration agreement, bringing the …
Immunocore to present at the 2025 Jefferies Global Healthcare Conference
GlobeNewswire
·
June 2, 2025
(OXFORDSHIRE, England …
Nokia and Andorix partner to accelerate Private 5G and Edge solutions in North American real estate market
GlobeNewswire
·
June 2, 2025
Press Release Nokia and Andorix partner to accelerate Private 5G and Edge solutions in North American real estate market Private 5G, Neutral Host Network and Edge Application OT solutions enabled by Nokia Digital Automation Cloud (DAC) to enable efficient …
Plum Wins Gold at the 5th Annual 2025 Globee® Awards for Disruptors
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Revolutionary pre-hire assessment provider Plum is proud to announce that it has been named a winner of the Gold Technology Industry Disruptor at the 5th Annual 2025 Globee® Awards for Disruptors, a prestigious …
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
GlobeNewswire
·
June 2, 2025
LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- InStride, a leading provider of strategic education and skilling solutions, has facilitated a unique partnership between Arizona State University’s College of Health Solutions and Labcorp, a global leader of …
Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
GlobeNewswire
·
June 2, 2025
LYTENAVA™ is the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK) 2.8 million injections of repackaged off-label bevacizumab in Europe each year1 ISELIN, N.J., …
Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi
GlobeNewswire
·
June 2, 2025
--Completion of GLP toxicology studies associated with a $50 million payment to Recludix under the collaboration with Sanofi -- REX-8756 is a potent and selective oral STAT6 inhibitor that demonstrates complete pathway inhibition and is well tolerated in …
CW Petroleum Corp (OTCQB: CWPE) Shareholder Update 6/2/2025
GlobeNewswire
·
June 2, 2025
Katy, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- CW Petroleum Corp (OTCQB: CWPE) (the “Company”), a leading provider of Specialty Renewable and Hydrocarbon Motor Fuels, today announces to its investors and future investors the Company remains on track to …
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)
GlobeNewswire
·
June 2, 2025
ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078) ENLIGHTEN 2 trial also showed statistically significant improvement …
Instil Bio Announces Appointment of Jamie Freedman, M.D., Ph.D., as Chief Medical Officer
GlobeNewswire
·
June 2, 2025
DALLAS, June 02, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel cancer therapies, today announced the appointment of Jamie Freedman, M.D., Ph.D., as …
Denodo University Challenge Now Open: Data and AI for Real-World Impact
GlobeNewswire
·
June 2, 2025
PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Denodo, a leader in data management, announced that the Denodo Academic Program, which prepares students to become future leaders in the field of data and analytics, has opened registration for the next …
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
GlobeNewswire
·
June 2, 2025
SAN FRANCISCO and VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced new preclinical …
Rocky Shore Announces the Sale of its Hemlo-Area Claims
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Rocky Shore Gold Ltd. (the “Company”) (CSE:RSG) is pleased to announce that it has entered into a definitive agreement (the “Agreement”) with a subsidiary of Barrick Mining Corporation (“Barrick”) to sell its …
Aura Minerals Agrees to Acquire the Mineração Serra Grande Gold Mine in Goiás, Brazil
GlobeNewswire
·
June 2, 2025
ROAD TOWN, British Virgin Islands, June 02, 2025 (GLOBE NEWSWIRE) -- Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to announce that Aura, AngloGold Ashanti plc (“AngloGold”) and a wholly owned subsidiary of …
Kymera Therapeutics Announces Positive First-in-Human Results from Phase 1 Healthy Volunteer Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader
GlobeNewswire
·
June 2, 2025
Phase 1 healthy volunteer data of KT-621, a once-a-day STAT6 degrader, surpass Kymera’s target product profile, significantly derisking program and further validating its oral, biologics-like profile >90% mean STAT6 degradation in blood achieved at all …
Big Names & Fresh Faces Headline Rogers Sports & Media’s Canadian Originals Slate for HGTV and Food Network
GlobeNewswire
·
June 2, 2025
– Rogers Sports …
Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
GlobeNewswire
·
June 2, 2025
– Robust broad-spectrum efficacy sustained over 1-year across all symptom domains including negative symptoms – – Generally well-tolerated with low rates of adverse events and discontinuation – – Brilaroxazine improved multiple neuroinflammatory markers …
De grands noms et de nouveaux visages dans les productions originales canadiennes de Rogers Sports & Média sur HGTV et Food Network
GlobeNewswire
·
June 2, 2025
– Rogers Sports …
Vanguard Food LP Announces Closing of Transaction to Create Emerging Leader in North American Produce Industry
GlobeNewswire
·
June 2, 2025
– Transaction creates new joint-venture in the North American produce industry backed by private investment firms – – Parties intend to provide additional capital to execute a roll-up strategy of other produce assets and operations – LAKE MARY, Fla., June …